These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37523417)

  • 1. Prevalence of and Factors Associated With Extraintestinal Manifestations and Their Remission in Inflammatory Bowel Disease: The EXTRA-Intestinal Manifestation Prospective Study From the Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif.
    Guillo L; Savoye G; Amiot A; Gilletta C; Nachury M; Dib N; Bourreille A; Roblin X; Caillo L; Allez M; Picon L; Hébuterne X; Seksik P; Chupin A; Buisson A; Brixi H; Altwegg R; Simon M; Amil M; Laharie D; Bouguen G; Serrero M; Elgharabawy Y; Peyrin-Biroulet L;
    Clin Transl Gastroenterol; 2023 Dec; 14(12):e00607. PubMed ID: 37523417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
    King D; Chandan JS; Thomas T; Nirantharakumar K; Reulen RC; Adderley NJ; Trudgill N
    Inflamm Bowel Dis; 2021 Oct; 27(11):1731-1739. PubMed ID: 34669933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.
    Karmiris K; Avgerinos A; Tavernaraki A; Zeglinas C; Karatzas P; Koukouratos T; Oikonomou KA; Kostas A; Zampeli E; Papadopoulos V; Theodoropoulou A; Viazis N; Polymeros D; Michopoulos S; Bamias G; Kapsoritakis A; Karamanolis DG; Mantzaris GJ; Tzathas C; Koutroubakis IE
    J Crohns Colitis; 2016 Apr; 10(4):429-36. PubMed ID: 26721936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.
    Tadbiri S; Peyrin-Biroulet L; Serrero M; Filippi J; Pariente B; Roblin X; Buisson A; Stefanescu C; Trang-Poisson C; Altwegg R; Marteau P; Vaysse T; Bourrier A; Nancey S; Laharie D; Allez M; Savoye G; Gilletta C; Gagniere C; Vuitton L; Viennot S; Aubourg A; Pelletier AL; Bouguen G; Abitbol V; Fumery M; Claudepierre P; Bouhnik Y; Amiot A;
    Aliment Pharmacol Ther; 2018 Feb; 47(4):485-493. PubMed ID: 29250803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID.
    Bacha RA; Bouhnik Y; Serrero M; Filippi J; Roblin X; Bourrier A; Bouguen G; Franchimont D; Savoye G; Buisson A; Louis E; Nancey S; Abitbol V; Reimund JM; DeWit O; Vuitton L; Mathieu N; Peyrin-Biroulet L; Gilletta C; Allez M; Viennot S; Berre CL; Laharie D; Nachury M; Amiot A;
    Dig Liver Dis; 2023 Dec; 55(12):1632-1639. PubMed ID: 37246095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking increases the risk of extraintestinal manifestations in Crohn's disease.
    Ott C; Takses A; Obermeier F; Schnoy E; Müller M
    World J Gastroenterol; 2014 Sep; 20(34):12269-76. PubMed ID: 25232261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study.
    Ramos GP; Dimopoulos C; McDonald NM; Janssens LP; Hung KW; Proctor D; Ruggiero E; Kane S; Bruining DH; Faubion WA; Raffals LE; Loftus EV; Al-Bawardy B
    Inflamm Bowel Dis; 2021 Jul; 27(8):1270-1276. PubMed ID: 33165569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease.
    Hertz S; Anderson JM; Nielsen HL; Schachtschneider C; McCauley KE; Özçam M; Larsen L; Lynch SV; Nielsen H
    Ann Med; 2024 Dec; 56(1):2338244. PubMed ID: 38648495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients.
    Roth R; Vavricka S; Scharl M; Schreiner P; Safroneeva E; Greuter T; Zeitz J; Misselwitz B; Schoepfer A; Barry MP; Rogler G; Biedermann L;
    United European Gastroenterol J; 2021 Sep; 9(7):773-780. PubMed ID: 34431613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry.
    Algaba A; Guerra I; Ricart E; Iglesias E; Mañosa M; Gisbert JP; Guardiola J; Mínguez M; Castro B; de Francisco R; Nos P; Bertoletti F; Mesonero F; Barrio J; Martín-Arranz MD; Calvet X; García-López S; Sicilia B; Alcaín G; Esteve M; Márquez L; Piqueras M; Jiménez L; Perez-Calle JL; Bujanda L; García-Sepulcre M; Fernández A; Moraleja I; Lorente RH; García-Bosch O; Lambán A; Blázquez I; Rodríguez E; Huguet JM; Lucendo AJ; Almela P; Busquets D; Ramírez de la Piscina P; Pérez M; Domenech E; Bermejo F;
    Dig Dis Sci; 2021 Jun; 66(6):2014-2023. PubMed ID: 32671587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Khrom M; Long M; Dube S; Robbins L; Botwin GJ; Yang S; Mengesha E; Li D; Naito T; Bonthala NN; Ha C; Melmed G; Rabizadeh S; Syal G; Vasiliauskas E; Ziring D; Brant SR; Cho J; Duerr RH; Rioux J; Schumm P; Silverberg M; Ananthakrishnan AN; Faubion WA; Jabri B; Lira SA; Newberry RD; Sandler RS; Xavier RJ; Kugathasan S; Hercules D; Targan SR; Sartor RB; Haritunians T; McGovern DPB
    Gastroenterology; 2024 Jul; 167(2):315-332. PubMed ID: 38490347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits.
    Taleban S; Li D; Targan SR; Ippoliti A; Brant SR; Cho JH; Duerr RH; Rioux JD; Silverberg MS; Vasiliauskas EA; Rotter JI; Haritunians T; Shih DQ; Dubinsky M; Melmed GY; McGovern DP
    J Crohns Colitis; 2016 Jan; 10(1):43-9. PubMed ID: 26449790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoma in Patients with Inflammatory Bowel Disease: A Multicentre Collaborative Study Between GETAID and LYSA.
    Muller M; Broséus J; Guilloteau A; Wasse S; Thiéblemont C; Nancey S; Cadiot G; Amiot A; Laharie D; Vieujean S; Bouhnik Y; Martineau C; Michiels C; Hebuterne X; Savoye G; Franchimont D; Seksik P; Beaugerie L; Maynadié M; Feugier P; Peyrin-Biroulet L
    J Crohns Colitis; 2024 Apr; 18(4):533-539. PubMed ID: 37850555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the Presence, Activity, and Status of Extraintestinal Manifestations of Inflammatory Bowel Disease Using Natural Language Processing of Clinical Notes.
    Stidham RW; Yu D; Zhao X; Bishu S; Rice M; Bourque C; Vydiswaran VVG
    Inflamm Bowel Dis; 2023 Apr; 29(4):503-510. PubMed ID: 35657296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease.
    Severs M; van Erp SJ; van der Valk ME; Mangen MJ; Fidder HH; van der Have M; van Bodegraven AA; de Jong DJ; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; van de Meeberg PC; Mahmmod N; Ponsioen CY; Bolwerk C; Vermeijden JR; Pierik MJ; Siersema PD; Leenders M; van der Meulen-de Jong AE; Dijkstra G; Oldenburg B;
    J Crohns Colitis; 2016 Apr; 10(4):455-61. PubMed ID: 26721937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).
    Gagnière C; Bourrier A; Seksik P; Gornet JM; DeWit O; Nancey S; Altwegg R; Abitbol V; Laharie D; Reenaers C; Buisson A; Pariente B; Viennot S; Vuitton L; Stefanescu C; Marteau P; Bouguen G; Cosnes J; Amiot A;
    Aliment Pharmacol Ther; 2018 Oct; 48(7):713-722. PubMed ID: 30069921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease.
    Jose FA; Garnett EA; Vittinghoff E; Ferry GD; Winter HS; Baldassano RN; Kirschner BS; Cohen SA; Gold BD; Abramson O; Heyman MB
    Inflamm Bowel Dis; 2009 Jan; 15(1):63-8. PubMed ID: 18626963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraintestinal manifestation of inflammatory bowel disease in Asian patients: A multinational study.
    Park SK; Wong Z; Park SH; Vu KV; Bang KB; Piyachaturawat P; Myint T; Hilmi I; Park DI
    Dig Liver Dis; 2021 Feb; 53(2):196-201. PubMed ID: 32736897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extra-intestinal manifestation of IBD in Veszprém county (of Hungary): results of a 25-years follow-up study].
    Lakatos L; Pandur T; Dávid G; Balogh Z; Küronya P; Tollas A; Lakatos PL
    Orv Hetil; 2003 Oct; 144(40):1965-75. PubMed ID: 14626638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia.
    Juliao-Baños F; Arrubla M; Osorio L; Camargo J; Londoño J; Cáceres C; Carvajal J; Mosquera-Klinger G; Donado J
    Gastroenterol Hepatol; 2021; 44(6):398-404. PubMed ID: 33172691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.